Cargando…
Dual inhibition of BRD4 and PI3K-AKT by SF2523 suppresses human renal cell carcinoma cell growth
Bromodomain-containing protein 4 (BRD4) and PI3K-AKT are both important for renal cell carcinoma (RCC) development and progression. SF2523 is a BRD4 and PI3K-AKT dual inhibitor. The present study demonstrated that SF2523 was cytotoxic and anti-proliferative to established RCC cell lines (786-O and A...
Autores principales: | Zhu, Hua, Mao, Jia-Hui, Wang, Yin, Gu, Dong-Hua, Pan, Xiao-Dong, Shan, Yuxi, Zheng, Bing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5716743/ https://www.ncbi.nlm.nih.gov/pubmed/29228703 http://dx.doi.org/10.18632/oncotarget.21432 |
Ejemplares similares
-
Preclinical Evaluation of a Novel Dual Targeting PI3Kδ/BRD4 Inhibitor, SF2535, in B-Cell Acute Lymphoblastic Leukemia
por: Ruan, Yongsheng, et al.
Publicado: (2021) -
2523 Noninvasive biomarkers for inflammatory bowel disease: Drawbacks and potential
por: Patel, Vihang, et al.
Publicado: (2018) -
2523: Mentor training for KL2 Scholars through vertical integration
por: Merrifield, Angela, et al.
Publicado: (2018) -
Learning from 2523 trauma deaths in India- opportunities to prevent in-hospital deaths
por: Roy, Nobhojit, et al.
Publicado: (2017) -
PB2523: DI-2-ETHYLHEXYL PHTHALATE (DEHP) INHIBITS HEMOGLOBIN S POLYMERIZATION
por: Camacho, Rodrigo Abreu, et al.
Publicado: (2023)